Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Focused Ultrasound Eases Fibroid Symptoms

All women in the study showed significant symptom relief three months after treatment


Related Encyclopedia
 border=
AIDS and HIV Infection
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Nutrition and Osteoporosis
Controlling Incontinence
Preventing Heart Disease the Easy Way
Lifestyle Changes for Heart Disease Prevention and Treatment
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Cialis
Detrol LA
Diflucan
More...

Related News Articles
 border=
Tobacco Plants Treat Cancer
Ease Mammogram Pain
Eating Habits
Hope for Dialysis Patients
More...

WEDNESDAY, May 30 (HealthDay News) -- A noninvasive ultrasound procedure called magnetic resonance-guided focused ultrasound surgery (MRgFUS) shrinks uterine fibroids and relieves fibroid-related symptoms.

That's the conclusion of a new study by researchers at Harvard Medical School and Brigham and Women's Hospital in Boston.

Text Continues Below



Uterine fibroids are benign growths of the muscle inside the uterus and are the primary reason for surgical removal of the uterus, accounting for about one-third of hysterectomies in the United States, according to the National Women's Health Information Center.

The study included 160 women with uterine fibroids, which can cause symptoms such as excessive menstrual bleeding, enlarged uterine size, frequent urination, pelvic pressure or pain, and infertility. Magnetic resonance imaging was used to identify and define the fibroids and MRgFUS was then used to treat the targeted fibroids.

Of the women in the study, 96 were treated under the original study protocol, which allowed a maximum treatment time of 120 minutes and a maximum fibroid treatment volume of 100 ccs (about 6 centimeters in diameter), or about 33 percent of total fibroid volume.

Sixty-four of the women were treated under an optimized protocol that allowed a maximum treatment time of 180 minutes and maximum fibroid treatment volume of 150 ccs (about 7 centimeters in diameter) -- about 33 percent of total volume in subserosal fibroids (those on the outer wall of the uterus), and 50 percent of volume in non-subserosal fibroids.

All the women showed significant symptom relief three months after treatment and sustained relief after one year. But those treated with the optimized treatment reported greater symptom relief and improved quality of life. No serious side effects were reported.

"This treatment immediately stops blood flow in the treated fibroid tissue, which results in a significant, sustained decrease in symptoms for up to 12 months," study lead author Dr. Fiona M. Fennessy, assistant professor of radiology at Harvard Medical School and staff radiologist at Brigham and Women's Hospital, said in a prepared statement.

Page:  1 | 2 | Next >>

-- Robert Preidt

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/30/2007

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





New Features

New ADHD Site!

SOURCE: Radiological Society of North America, news release, May 29, 2007


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service